宜明昂科生物医药技术（上海）股份有限公司（股票代码：01541，股票简称：宜明昂科-B）于2026年4月8日发布2026年3月股份变动月报表。报告期内，公司注册股本未发生增减变动，股本结构保持稳定。
公司现有已发行H股数量为420,477,305股，折合注册股本约人民币4.20亿元；非上市股份数量为11,030,390股，折合注册股本约1,103.04万元。截至2026年3月31日，注册股本总额约人民币4.32亿元。报告期内，未发生股份新增发行、购回、注销或庫藏股变动，也无期权及股权激励计划调整事项。
公告显示，公司确认满足香港联交所的最低公众持股量要求。该公告由执行董事、联席公司秘书关梅签署。公司表示将继续严格遵守香港联合交易所有限公司《上市规则》及相关法律法规。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.